Natural compounds targeting ferroptosis in ovarian cancer: Research progress and application potential
- PMID: 40194611
- DOI: 10.1016/j.phrs.2025.107729
Natural compounds targeting ferroptosis in ovarian cancer: Research progress and application potential
Abstract
Ovarian cancer (OC) is among the most common malignancies in the female reproductive system, marked by high rates of recurrence and mortality. Conventional chemotherapy, however, faces limitations due to the development of drug resistance, which hinders its effectiveness. Ferroptosis, an atypical form of programmed cell death distinct from autophagy, apoptosis, and necrosis, the relationship with tumors has become a hot research area in cancer studies in recent years. Anticancer therapies that target ferroptosis show strong potential in improving prognosis and counteracting chemotherapy resistance. Natural compounds, as a valuable source of novel targeted anticancer agents, its significant role in inhibiting tumor cell proliferation and metastasis and improving therapeutic sensitivity has been demonstrated in numerous existing studies. This review summarizes a range of natural compounds that target ferroptosis in OC cells, discussing their active components, mechanisms of action, and therapeutic potential, thereby providing useful insights for future targeted therapy and research in OC.
Keywords: Ferroptosis; Iron; Natural compounds; Ovarian cancer; Reactive oxygen species.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance.Life Sci. 2024 Jul 15;349:122720. doi: 10.1016/j.lfs.2024.122720. Epub 2024 May 16. Life Sci. 2024. PMID: 38762066 Review.
-
Ferroptosis: An emerging strategy for managing epithelial ovarian cancer.Biomed Pharmacother. 2025 Jun;187:118065. doi: 10.1016/j.biopha.2025.118065. Epub 2025 Apr 29. Biomed Pharmacother. 2025. PMID: 40306179 Review.
-
Natural products and the balancing act of autophagy-dependent/independent ferroptosis in cancer therapy.Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2531-2549. doi: 10.1007/s00210-023-02782-1. Epub 2023 Oct 25. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37878043 Review.
-
Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer.J Adv Res. 2024 Nov;65:89-104. doi: 10.1016/j.jare.2024.04.033. Epub 2024 May 7. J Adv Res. 2024. PMID: 38724006 Free PMC article.
-
High-adhesion ovarian cancer cell resistance to ferroptosis: The activation of NRF2/FSP1 pathway by junctional adhesion molecule JAM3.Free Radic Biol Med. 2025 Feb 16;228:1-13. doi: 10.1016/j.freeradbiomed.2024.12.040. Epub 2024 Dec 18. Free Radic Biol Med. 2025. PMID: 39706500
Cited by
-
Fucoidan-decorated metal-zoledronic acid nanocomplexes suppress tumor metastasis by inducing ferroptotic cell death and enhancing cancer immunotherapy.J Nanobiotechnology. 2025 Jun 2;23(1):405. doi: 10.1186/s12951-025-03473-0. J Nanobiotechnology. 2025. PMID: 40452005 Free PMC article.
-
Crosstalk between ferroptosis and endoplasmic reticulum stress: A potential target for ovarian cancer therapy (Review).Int J Mol Med. 2025 Jun;55(6):97. doi: 10.3892/ijmm.2025.5538. Epub 2025 May 2. Int J Mol Med. 2025. PMID: 40314096 Free PMC article. Review.
-
Molecular Mechanisms of Phytochemicals from Chaga Mushroom (Inonotus obliquus) Against Colorectal Cancer: Insights from Network Pharmacology, Molecular Docking, and Bioinformatics.Int J Mol Sci. 2025 Aug 8;26(16):7664. doi: 10.3390/ijms26167664. Int J Mol Sci. 2025. PMID: 40868987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical